Product returns create friction for consumers, negatively impact profit margins for companies, and result in significant inefficiencies in inventory utilization throughout the supply chain. To combat these challenges, Blue Yonder, the world leader in end-to-end digital supply chain transformation, announced today it has acquired Optoro, Inc., a leading technology provider for returns, to enhance its Returns Management capabilities, delivering a more robust, comprehensive solution. Returns pro...

Neumirna Therapeutics, a biotechnology company developing RNA-based therapies for neurological diseases, today announced the appointment of Ellen K. Donnelly, Ph.D. as Chief Executive Officer. Ellen brings more than 20 years of leadership in neuroscience and rare diseases, spanning both global pharmaceutical companies and innovative biotech firms. She joins Neumirna from her role as CEO of Abliva AB, recently acquired by Pharming Group, and has previously led Modus Therapeutics and Souvien Th...